This inventor holds 1 USPTO granted patent. Top assignee: Joslin Diabetes Center, Inc.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Innovations by Luis Castano in Diabetes Treatment
Introduction
Luis Castano is an accomplished inventor based in Asturias, Spain. He has made significant contributions to the field of diabetes research, particularly in the development of therapeutic agents that target insulin autoantibodies. His work is crucial for advancing treatment options for individuals with diabetes.
Latest Patents
Luis Castano holds a patent for "Peptides having insulin autoantibody but not insulin receptor binding." This innovative therapeutic agent includes a purified peptide bound to a cytotoxic moiety. The peptide is specifically reactive with human insulin autoantibodies and non-reactive with the human insulin cell surface receptor. This patent represents a significant advancement in diabetes treatment.
Career Highlights
Luis Castano is affiliated with the Joslin Diabetes Center, Inc., where he continues to work on groundbreaking research. His expertise in the field of diabetes has positioned him as a key figure in developing new therapeutic strategies.
Collaborations
Throughout his career, Luis has collaborated with notable professionals in the field, including George S. Eisenbarth and Steven E. Shoelson. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Luis Castano's contributions to diabetes research through his innovative patents and collaborations highlight his commitment to improving treatment options for patients. His work continues to inspire advancements in the field of diabetes therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile